Only 4-in-10 people who received a tax-payer funded screeningtest in the mail during 2016-17 used it, according to the latest data released by the Australian Institute of Health and Wellbeing (AIHW).
The results were disappointing, revealing little change in participation rates in the National Bowel Cancer Screening Program (NBCSP) over recent years.
Between January 2016 and December 2017, only four in ten (41.3%) Australians invited to screen took up the potentially life-saving opportunity.
Participation was lowest in Halls Creek, Western Australia, at just 8%.
The highest uptake was seen in Yorke Peninsula – South, in South Australia, where 59% of those invited to participate returned their samples for testing.
Millions of people around the world will mobilise today (February 4th) to help make progress against the world’s most deadly disease, in recognition of World Cancer Day.
Whoever you are, you have the power to reduce the impact of (bowel) cancer for yourself, the people you love and for the world.
Whoever you are, you have the power to reduce the impact of cancer for yourself, the people you love and for the world.
Next Monday is World Cancer Day and we’re calling on all Australians to join the global effort to raise (bowel) cancer awareness and encourage everyone around the world to take action!
A blood test which detects reliable biomarkers for early-stage diagnosis of bowel cancer is something Subroto B. Chatterjee, M.S., M.Sc., Ph.D., a professor of paediatrics and a specialist in vascular biology, believes would be welcome by patients and clinicians alike.
Screening using a faecal immunochemical test (FIT) can detect blood in a person's faeces that is invisible to the human eye, but a bowel cancer diagnosis still requires a colonoscopy to determine the cause of the bleeding.
Dr Chatterjee and his team at John Hopkins in the United States have discovered a protein which could serve as a marker for the early detection of bowel cancers, that could be detected via a blood test.